Company search
Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Data as at: 08/12/2025
In
Objective
To generate long-term capital appreciation by investing in a globally diversified portfolio of healthcare companies, to include, but not limited to, pharmaceutical, biotechnology, medical device and healthcare services companies.
AIC sector
Management group
Company website
Launch date
15/06/2010
September
Domicile
United Kingdom
Fund manager
David Pinniger, James Douglas, Deane Donnigan, Gareth Powell
Dividend frequency
Semi-Annually
Wind-up provisions
The Board intends to review the Company’s future and may propose alternative arrangements for shareholder approval before the 2026 AGM. If not approved, a resolution to liquidate the Company will be proposed at the 2026 AGM.
391.21
| Share type | Market Cap (m) | Total assets (m) | Price (last close) | NAV | Discount / premium (%) | Gearing (%) | Dividend yield (%) | Dividend dates | Ongoing charge (%) |
|---|---|---|---|---|---|---|---|---|---|
| Ordinary Share | 392.99 | 391.21 | 418.00 | 416.11 | 0.93 | 0 | 0.57 | Feb, Aug | 0.88 (30/09/2024) |
Scroll
Dividends
Dividends declared in last 12 months
| Ex-dividend date | Payment date | Dividend amount | Special dividend | Financial year |
|---|---|---|---|---|
| 07/08/2025 | 29/08/2025 | 1.200 | No | 2025 |
| 06/02/2025 | 28/02/2025 | 1.200 | No | 2024 |
Scroll
Performance (%)
| Return type | 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|---|
| Polar Capital Global Healthcare | Share price total return | 15.6 | 31.6 | 80.2 | 163.2 |
| Biotechnology & Healthcare AIC sector | Share price total return | N/A | N/A | N/A | N/A |
Scroll
Share structure
2,879,256
Traded volumes (number of shares)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Polar Capital Glb Healthcare Ord Total | 268,042 | 40,827,875 | 107,837,466 | 303,467,164 |
| Polar Capital Glb Healthcare Ord Average | N/A | 1,944,190 | 426,235 | 240,656 |
Scroll
Traded values (m)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Polar Capital Glb Healthcare Ord Total | 1.12 | 171.34 | 404.52 | 1,027.50 |
| Polar Capital Glb Healthcare Ord Average | N/A | 8.16 | 1.60 | 0.81 |
Scroll
Trading details
| ISIN | Ticker | Traded currency | Stock exchange |
|---|---|---|---|
| GB00B6832P16 | PCGH | GBX | London Stock Exchange - MAIN Chi-x Europe Limited London Stock Exchange |
Scroll
Top holdings
Data as at : 31/10/2025
| Investment | % of total assets |
|---|---|
| Eli Lilly and Co | 9.7 |
| AstraZeneca PLC | 5.2 |
| Thermo Fisher Scientific Inc | 4.7 |
| CVS Health Corp | 3.8 |
| Boston Scientific Corp | 3.6 |
| Teva Pharmaceutical Industries Ltd ADR | 3.6 |
| UCB SA | 3.4 |
| Fresenius SE & Co KGaA | 3.3 |
| Insulet Corp | 3.2 |
| West Pharmaceutical Services Inc | 3.1 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.
